|
HS Code |
225505 |
| Chemicalname | 5-Bromo-2-[(2R)-5-Bromo-2,3-Dihydro-1H-Indol-2-Yl]Phenol |
| Molecularformula | C14H11Br2NO |
| Molecularweight | 385.06 g/mol |
| Casnumber | 1428553-56-7 |
| Appearance | Off-white to light yellow solid |
| Solubility | DMSO, methanol (soluble) |
| Purity | Typically ≥98% |
| Storagecondition | Store at -20°C, protect from light and moisture |
| Synonyms | BRD-K43292592 |
| Smiles | C1CC2=CC(=C(C=C2NC1)Br)C3=C(C=CC(=C3)Br)O |
| Inchi | InChI=1S/C14H11Br2NO/c15-9-5-10(8-13(17)6-9)12-7-11-2-1-3-14(11)16-12/h5-8,12,16-17H,1-4H2/t12-/m1/s1 |
| Chirality | (2R)-configuration |
| Application | Research compound |
As an accredited 5-Bromo-2-[(2R)-5-Bromo-2,3-Dihydro-1H-Indol-2-Yl]Phenol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is packaged in a 10g amber glass bottle with a tamper-evident cap, labeled with hazard warnings and product details. |
| Shipping | Shipping for 5-Bromo-2-[(2R)-5-Bromo-2,3-Dihydro-1H-Indol-2-Yl]phenol is conducted in accordance with relevant chemical transport regulations. The compound is securely packaged in sealed containers, clearly labeled, and shipped with proper documentation. Temperature control and hazardous material handling protocols are followed to ensure safe delivery to the specified destination. |
| Storage | Store **5-Bromo-2-[(2R)-5-Bromo-2,3-dihydro-1H-indol-2-yl]phenol** in a tightly sealed container, away from direct sunlight in a cool, dry, and well-ventilated area. Keep it separated from incompatible substances such as strong oxidizers. Ensure storage in a designated chemical storage area with appropriate labeling, and limit access to trained personnel. Avoid exposure to moisture and sources of ignition. |
Competitive 5-Bromo-2-[(2R)-5-Bromo-2,3-Dihydro-1H-Indol-2-Yl]Phenol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615380400285 or mail to sales2@liwei-chem.com.
We will respond to you as soon as possible.
Tel: +8615380400285
Email: sales2@liwei-chem.com
Flexible payment, competitive price, premium service - Inquire now!
We have seen organic chemistry push the boundaries of both pharmaceutical innovation and advanced plastics over the past decade. One material that continues to draw attention in R&D labs is 5-Bromo-2-[(2R)-5-Bromo-2,3-Dihydro-1H-Indol-2-Yl]Phenol. Our own experience as a chemical manufacturer shapes how we talk about its nuances and potential, as well as some of the challenges and advantages unique to this compound.
This molecule’s backbone is based on a phenolic core with two bromine atoms and a fused dihydroindole system. Placing the 5-bromo substitution on both the indole ring and phenol itself allows for a set of reactivity profiles that do not appear in simpler indole or phenol derivatives. Chemists appreciate the ready access to both electron-donating and electron-withdrawing effects within a single molecule, which is not a trivial achievement in brominated aromatic chemistry.
Working directly with the synthesis daily, our teams navigate the delicate processes needed to deliver high chemical purity batch after batch. Brominated compounds can lead to problems with selectivity during halogenation, so avoiding unwanted by-products or overhalogenation becomes a persistent question. Through continuous monitoring, targeted reaction control, and multiple recrystallization cycles, we consistently supply >98% purity in bulk, confirmed by NMR and HPLC. This profile is something we have honed after numerous iterative scale-ups and accompanying challenges.
Our product commonly leaves our plant as an off-white to faintly tan crystalline powder. The melting point appears in a tight range, based both on consistent batch records and cross-comparison using parallel methods. Knowing that some end-users demand particle sizes that flow well in both wet and dry blend applications, we have tailored drying and milling parameters so most lots offer a controlled d50 around 80 microns. Our Standard Operating Procedures monitor not just active concentration but also residual solvents and trace metal content, since these can affect downstream activities.
The final packing step reflects feedback from users as well as from our own experience in process safety and minimization of internal loss: double-lined, thick-walled polyethylene drums with tamper-evident closures guard against both moisture ingress and dust escape. Typical lot sizes range from research ball jars (under 100g) to full production drums, since most of this material is used where flexibility and speed matter to customers.
Technically, there are other bromo-indole derivatives on the market, and some can seem interchangeable at first glance. Feedback from formulation groups and process chemists reveals the real distinctions. Subtle molecular architecture makes this material more predictable in Suzuki coupling, for example, allowing for a steadier, higher yield across different catalyst systems. Our direct experience working next to kilolab reactors has shown lower tar formation and easier filtration than with analogs carrying the bromo group elsewhere on the core ring.
There’s also a safety factor: The reactivity of brominated aromatics can present hazards in scale, especially exothermic runaway. Thanks to repeated pilot runs, we now guide customers to work with staged additions and tight temperature ramps—advice springing from our own investments in process safety rather than theoretical risk. We see one recurring misconception about this molecule: Some users expect its properties to mirror simpler indole bromides, only to find altered solubility and a reduced likelihood of forming stubborn emulsions during quench stages.
Our main clients use this molecule in advanced heterocyclic synthesis, targeting kinase inhibitors or other bioactive molecule scaffolds. The structure allows medicinal chemists to attach diverse pharmacophores with minimal need for downstream protection and deprotection steps, making structure-activity relationship studies more efficient. Some customers have also explored this compound in the development of organic electronic materials, capitalizing on bromine’s impact on electron mobility within conjugated systems.
Several innovation teams have come back to us remarking how predictable the coupling reactions are compared to single-bromo or unprotected indole/phenol combinations. Clean conversion and better overall step economy win out when timelines and IP race considerations take center stage. We routinely share analytical data confirming lot-to-lot consistency to help smooth project transitions from exploratory batch to clinical or scale-up stages.
As manufacturers, we have to look beyond simply making a product workable in R&D. In scaling up, we have run headlong into bromine management issues. Waste minimization drives part of our process engineering: By tightly controlling reaction stoichiometry, continuous extraction, and gas scrubbing, we have reduced both waste generation and plant operator exposure. These operational realities seldom make it into published literature, though they shape every production cycle.
Regulatory scrutiny of brominated aromatics has sharpened in the last few years. We have adapted our quality regime and documentation practices so customers can submit their own filings with confidence. Our internal assays track not just the typical purity thresholds, but also emerging global norms around controlled impurities, genotoxin screening, and green chemistry. Failures to meet these benchmarks often mean expensive rework and shipment delays. Years in manufacturing have taught us the value of walking audits, process mapping, and real-time documentation more than any accumulation of formal compliance checklists.
Packaging and storage become crucial for customers moving their projects through ever-stricter regulatory review. Tight moisture and air exclusion, tracked and logged right from drum to opening at your bench, help avoid trace decomposition and ensure data reproducibility across geographies. Small procedural changes in our prep room, such as integrating inert atmosphere handling and rapid nitrogen backfill, sprang up as direct answers to recurring customer issues.
Among available substituted indoles, 5-Bromo-2-[(2R)-5-Bromo-2,3-Dihydro-1H-Indol-2-Yl]Phenol stands out for its two-point reactivity. Compounds missing the second bromo group or lacking the phenolic oxygen do not deliver the same ease in further functionalization, especially across carbon-carbon coupling platforms. In our own hands, attempts to swap to the chloro or iodo analogs have bridged neither cost efficiency nor step selectivity. Some customers have explored using cheaper, lower-purity imports, only to see inconsistent yields and hard-to-troubleshoot artifact peaks on analytical traces.
Another practical difference shows up during process scale-up. Single bromo-indole compounds tend to suffer from batch heterogeneity, especially after prolonged basket drying, leading to caking or unexpected off-colors. Our production line, dialing in conditions for this specific di-bromo-phenolic system, allows for a clean, free-flowing powder every run. Our inspection logs across hundreds of bult lots confirm these gains—less time spent on rework, less scrap, and steadier project progress for downstream users.
For formulators working with sensitive secondary amination or phosphorylation steps, the stability of our product and its resistance to darkening or side-reaction under mild basic or acidic conditions has closed the gap for at least three client drug development programs looking to improve candidate throughput. Not every substituted indole delivers this kind of resilience outside drybox or strictly controlled environments.
Years running our own pilot plant and kilo lab have taught us the real issues start once the drums leave our loading dock. This is especially true for groups unfamiliar with large batch handling of halogenated aromatics. Phone calls, photos, and conference screens—more than one scale-up drama has crossed our desks. We always encourage new users to run a quick micro-batch under modified conditions to confirm reactivity and workup. Many customers—enthusiastic with a new pathway—overlook solvent compatibility or addition order. With this compound, a staggered alkylation or slow temperature ramp tends to avoid pressure surges, especially under basic conditions.
Failing to control exotherms can damage both yield and safety, as we learned in several early pilot trials. Publishing those lessons in internal reports, then baking them into technical guidance, means newcomers sidestep trouble with less wasted time or material. We invest in detailed batch packing records and product support documentation for a reason—making regulatory audits, tech transfer, and final product submissions more efficient for everyone.
Every suggestion, complaint, and success story coming back from our global user base becomes part of how we push forward. Our R&D team has already tweaked particle size control based on feedback from medicinal chemistry partners needing faster dissolution rates in automated platforms. The investment paid off with reports of fewer filter blockages and more reliable high-throughput screening results.
A recent request for ultra-low solvent residues from a customer working in peptide chemistry led us to install a parallel evaporation rack, trading throughput for quality. The impact rippled through several other product lines, raising standards plant-wide. Honest feedback from real-world use underpins every process change we make. That has proven more valuable than any marketing gloss or template wording meant to polish product reputation.
We know this is a competitive marketplace. Many buyers run quick, side-by-side evaluations against samples from both global catalogues and unbranded brokers. These head-to-head tests sometimes highlight subtle differences. Moisture stability or batch color might seem cosmetic, but the avoided rework and data reproducibility matter: we track customer change control forms, spot trends, and address root causes.
Buyers want not just a molecule, but a supply chain they don’t need to double-check at every stage of their project. We rebuilt our internal QA and documentation systems around this demand for predictability. Every batch gets its own audit trail, from raw input to final QC signoff. It’s common for a customer—especially in regulated pharma—to ask for historical impurity profiles or chain-of-custody tracking before approving a new supplier relationship. Our teams field these requests in real time, pulling digital records for easy review.
We believe in letting the numbers and consistency speak for themselves. Regular internal reviews compare COA data over time, and patterns from one lot go straight into refining the next. A commitment to standardization and traceability reduces troubleshooting calls down the line, saving customers time and reducing downtime. Major formulation groups have remarked on smooth process validation—a benefit only possible with careful, transparent daily work at the source.
As global regulations shift—especially in pharmaceutical filings and green chemistry goals—manufacturers like us have evolved too. We keep one ear open for emerging guidance from both industry groups and regulatory agencies. Minor process changes, such as stricter trace element controls or additional genotoxin screening, ripple across our daily routines. Far from viewing these as red tape, we have seen how smarter analytical controls reduce both internal rework and the risk of flagged audit findings.
Customers operating under strict QA/QC regimes appreciate real numbers and specific transparency. Our system now logs every batch’s instrumental data, not just shipment paperwork, to support customer documentation or compliance submissions. We don’t view this as a burden, but as the shape of serious, lasting partnerships in a changing market. A handful of nonconformances in early years taught us the value of preparation, so now even ad-hoc lot requests come with full data support.
The specialty chemical field faces increasing pressure to develop cleaner, less hazardous production. Years ago, we invested in modular reaction systems and advanced emission scrubbing for precisely this class of brominated intermediates. Lowering the bromine excess directly cut down hazardous effluent and spent wash volume. Integrated solvent recovery reduced both GHG emissions and logistics costs for bulk customers.
Several clients have shown growing interest not just in the chemical product, but also its carbon and safety footprint. Practical improvements—like switching to lined returnable drums, using better personal protective equipment for workers, and minimizing offcuts from bulk packaging—grow out of hands-on manufacturing, not just checkboxes for certifications. Product stewardship will shape future decision making, so we have already started collaborating with downstream users to repurpose off-spec or surplus product lots.
We have noticed more project managers sending audit teams to visit our site ahead of new program launches. That sort of scrutiny is welcome. Transparency in handling both product and waste, clean documentation, clear labeling, and accurate real-time reporting all matter, especially for a sensitive intermediate with multiple bromine substituents. Buyers want confidence in every aspect of the process—from receipt of the shipment to regulatory submissions years down the road.
The practical value of 5-Bromo-2-[(2R)-5-Bromo-2,3-Dihydro-1H-Indol-2-Yl]Phenol—the reason formulation groups, discovery chemists, and process engineers keep coming back—stems from both its chemical features and the way that daily work at scale transforms a theoretical pathway into a trusted supply. We keep daily logs, batch journals, and technical support records, constantly refining the process to offer both speed and reliability.
Our investment in dedicated support and process documentation means customers face fewer surprises. If a technical hold-up happens, they pick up the phone and reach a chemist or an operator who knows every step of the way this molecule was made. This commitment to knowledge sharing spans from advice about solvent swaps to warnings about quirky workup behavior discovered only after dozens of runs.
The more we listen, experiment, and improve, the more we see that the difference between off-the-shelf chemicals and a specialty product like this comes down to real, lived manufacturing experience. Our role is to share those lessons, build on hard-won technical advances, and keep open lines for guidance, tweaking, and course correction as chemical science—for pharma, materials, or beyond—keeps moving forward.